Back
Keros Therapeutics Vs. Expedia Group Industry Stock Comparison
Sell
11
KROS
Keros Therapeutics
Last Price:
52.21
Seasonality Move:
-8.67%
Sell
48
EXPE
Expedia Group
Last Price:
113.98
Seasonality Move:
8.66%
Sell
11
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $52.28. The Score for KROS is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
48
Expedia Group (EXPE)
is a Sell
Is Expedia Group a Buy, Sell or Hold?
- The current Expedia Group [EXPE] share price is $114.01. The Score for EXPE is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- EXPE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $52.28
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
EXPE Stock Price Chart
What is Expedia Group's stock price today?
-
The Expedia Group share price today is $114.01
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EXPE is experiencing slight buying pressure.
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.86 | Sell |
Relative Strength Index (14 RSI): | 36.33 | Sell |
Chaikin Money Flow: | -201681 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (54.48 - 59.02) | Sell |
Bollinger Bands (100): | (51.17 - 65.33) | Sell |
EXPE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.51 | Sell |
Relative Strength Index (14 RSI): | 32.68 | Sell |
Chaikin Money Flow: | 1004127 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (114.28 - 134.18) | Sell |
Bollinger Bands (100): | (125.67 - 148.45) | Sell |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.72 | Sell |
20-day SMA: | 56.32 | Sell |
50-day SMA: | 60.88 | Sell |
200-day SMA: | 45.45 | Buy |
8-day EMA: | 54.52 | Sell |
20-day EMA: | 56.43 | Sell |
50-day EMA: | 58.19 | Sell |
200-day EMA: | 50.75 | Buy |
EXPE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 112.87 | Buy |
20-day SMA: | 123.1 | Sell |
50-day SMA: | 129.38 | Sell |
200-day SMA: | 125.89 | Sell |
8-day EMA: | 114.63 | Sell |
20-day EMA: | 120.08 | Sell |
50-day EMA: | 127.21 | Sell |
200-day EMA: | 126.93 | Sell |
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.
Expedia Group Earnings Growth & EXPE Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.46 per share, a decrease next quarter of $2.62 per share, an increase this year of $2.12 per share, and an increase next year of $2.83 per share.
Keros Therapeutics Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Expedia Group Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |